Le Lézard
Classified in: Health
Subject: MAT

"Dateline NBC" Highlights Growing Interest in CBD


CARLSBAD, Calif., June 14, 2018 /PRNewswire/ -- On Sunday, May 20, "Dateline NBC" showcased the latest research on CBD or cannabidiol, focusing on its potential importance in managing serious ailments and enhancing wellness. With an ongoing focus on supporting greater health and wellness, industry leader CBD Naturals® is proud to use the latest CBD breakthroughs in its consumer products, including enhanced water, food, vitamins and skin care.

The NBC segment on CBD discussed recent changes in the medical landscape, highlighting the ability of the molecule to reduce seizures and treat epilepsy, CTE, opioid addiction and more. In April, the advisory committee to the Food and Drug Administration (FDA) voted unanimously to recommend the first prescription cannabidiol medicine to treat epilepsy.

"As an organization that has long recognized the amazing properties of CBD, it is encouraging to see more groups and individuals taking advantage of cannabidiol," said Jared Berry, founder and CEO of CBD Naturals® and former founder of Isodiol, now known as Isodiol International Inc. "We are proud to offer products for consumers passionate about eating, drinking and living well."

Carlsbad Naturals® products provide antioxidants at a cellular level, as well as a vitamin and mineral boost directly to the cells; they are designed to support hydration, energy and the immune system. CBD Naturals® is one of few brands to receive a registration mark from the USPTO, which is even more rare in the CBD/cannabis industry. It represents the first trademark to ever be filed with "CBD" in the name, evidence of its head start and innovation in the industry.

Unlike the well-known THC, another naturally occurring compound found in cannabis plants, CBD is not psychotropic.

About CBD Naturals®
Launched in 2011 by industry trailblazer Jared Berry, CBD Naturals® has logged an impressive list of industry firsts, including becoming the first CBD brand to ever be filed with the USPTO for trademark. Prior to filing for this intellectual property, a "CBD marketplace" didn't exist, marking Berry and his team of scientists the original trailblazers of the space. CBD Naturals® continues to pioneer scientific advancements in uncovering the full wellness potential of the cannabis plant. Using proprietary technology and industry leadership, they aim to bring the nutritional benefits of this plant to those interested in living a healthier life. For more information, please visit https://cbdnaturals.com

Contact:
Logan Lidster
[email protected]
844-877-7908

SOURCE CBD Naturals


These press releases may also interest you

at 02:48
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...

at 02:43
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM. The company aims to webcast the...

at 02:41
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website. "Implantica had a very...

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...

at 02:00
Amwins Global Risks is delighted to announce Classic Cars and Cotswolds, an auction to raise money for the Matthew Wilson Multiple Myeloma Fund at Blood Cancer UK. The online auction opens today and features Ferraris, Aston Martins, a Rolls Royce, a...

at 01:35
Regulatory News: Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces...



News published on and distributed by: